Evidence map›Paper›PMID 41514264›Full record

ArticleBMC medical ethics2026

Adapting research ethics for global health crises: a systematic analysis of COVID-19 pandemic research guidelines and reflections on their post-pandemic implications.

Vilma Lukaševičienė, Eugenijus Gefenas

Abstract read
In one paragraph

Article in BMC medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vilma LukaševičienėFaculty of Medicine, Institute of Health Sciences, Centre for Health Ethics, Law and History, Vilnius University, Vilnius, Lithuania. vilma.lukaseviciene@mf.vu.lt.ORCID 0000-0001-8277-7603
Eugenijus GefenasFaculty of Medicine, Institute of Health Sciences, Centre for Health Ethics, Law and History, Vilnius University, Vilnius, Lithuania.ORCID 0000-0001-5004-3322

Funding

European Union 101058094 - PREPARED - HORIZON-WIDERA-2021-ERA-01
6 · The paper itself

Abstract

backgroundthe COVID-19 pandemic posed unprecedented challenges to global research ethics governance. In response to the urgent need for rapid scientific data, ethics review processes were accelerated, informed consent procedures adapted, and new research methods introduced. These changes were guided by the proliferation of research ethics guidelines issued by national, regional and international bodies. However, there has been limited systematic analysis of how these guidelines addressed key ethical challenges during the pandemic and shaped future ethical frameworks. This study aims to map the global network of pandemic related research guidelines, to analyze how they addressed the main pandemic specific ethical challenges.

methodsWe conducted a systematic search of published research ethics and regulatory guidelines developed in response to the COVID-19 pandemic between 2020 and 2022. We applied a mixed methods approach: citation network analysis was used to visualize interconnections between guidelines and identify influential sources, and a thematic analysis was used to examine how guidelines addressed specific ethical issues.

resultsthe citation network analysis revealed a globally interconnected ethical framework with the WHO outbreak guidelines (2016) and CIOMS guidelines (2016) emerging as central references. Thematic analysis identified eight recurring ethical themes: research prioritization, research ethics oversight, inclusion of vulnerable populations, balancing risks and benefits, modifications of informed consent, data sharing and transparency, collaboration and preparedness, and public engagement. Guidelines encouraged procedural flexibilities (e.g., expedited reviews, e-consent) but also emphasized the need to maintain ethical rigor and scientific integrity. Tensions between speed and scrutiny, centralization and local context, public health goals and individual protection were recurring concerns. Integration of public health ethics, research integrity, and human rights frameworks emerged as a defining feature of most guidelines.

conclusionsCOVID-19 catalyzed a shift toward more integrated and adaptive research ethics frameworks that combine individual protection and collective public health goals. These shifts are being reflected in recent updates of major ethics instruments such as the Declaration of Helsinki and new policy initiatives such as the European Health Data Space Regulation. However, gaps remain in harmonization, implementation, and preparedness planning. Continuous efforts are needed to harmonize ethics guidance, support research ethics committees in crisis contexts, and integrate preparedness planning into global research ethics governance.

Indexed as

Biomedical ResearchCOVID-19Ethics, ResearchGlobal HealthGuidelines as TopicPandemicsHumansInformed ConsentSARS-CoV-2COVID-19 pandemic.Research ethicsResearch ethics committee

Identifiers

PMID41514264
PMCPMC12882123

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.